Cerecor Inc. (CERC) Reaches $3.90 After 5.00% Up Move; Encompass Capital Advisors Lowered Its Marathon Oil (MRO) Position

April 21, 2018 - By Dolores Ford

Marathon Oil Corporation (NYSE:MRO) Logo

Encompass Capital Advisors Llc decreased Marathon Oil Corp (MRO) stake by 9.55% reported in 2017Q4 SEC filing. Encompass Capital Advisors Llc sold 344,125 shares as Marathon Oil Corp (MRO)’s stock declined 6.39%. The Encompass Capital Advisors Llc holds 3.26M shares with $55.18 million value, down from 3.60 million last quarter. Marathon Oil Corp now has $15.38 billion valuation. The stock increased 0.17% or $0.03 during the last trading session, reaching $18.02. About 11.72M shares traded. Marathon Oil Corporation (NYSE:MRO) has risen 7.25% since April 21, 2017 and is uptrending. It has underperformed by 4.30% the S&P500.

The stock of Cerecor Inc. (NASDAQ:CERC) is a huge mover today! The stock increased 9.24% or $0.33 during the last trading session, reaching $3.9. About 389,252 shares traded or 28.26% up from the average. Cerecor Inc. (NASDAQ:CERC) has risen 497.18% since April 21, 2017 and is uptrending. It has outperformed by 485.63% the S&P500.The move comes after 6 months positive chart setup for the $122.38M company. It was reported on Apr, 21 by Barchart.com. We have $4.10 PT which if reached, will make NASDAQ:CERC worth $6.12M more.

Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. The company has market cap of $122.38 million. It develops CERC-501, which has completed Phase II clinical trial for the adjunctive treatment of major depressive disorder , as well as to treat substance use disorders; CERC-301 that has completed Phase II clinical trial for the adjunctive treatment of patients with MDD; and CERC-406 that is in preclinical stage to treat residual cognitive impairment symptoms in patients with MDD. It has a 9.29 P/E ratio. Cerecor Inc. also intends to develop CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy.

Among 2 analysts covering Cerecor (NASDAQ:CERC), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Cerecor has $10 highest and $1 lowest target. $5.50’s average target is 41.03% above currents $3.9 stock price. Cerecor had 2 analyst reports since December 9, 2015 according to SRatingsIntel. Rodman & Renshaw downgraded the stock to “Neutral” rating in Monday, December 12 report. The firm has “Buy” rating by Laidlaw given on Wednesday, December 9.

Encompass Capital Advisors Llc increased Weatherford Intl Plc (NYSE:WFT) stake by 1.50M shares to 3.75M valued at $15.64 million in 2017Q4. It also upped Southwestern Energy Co (NYSE:SWN) stake by 862,553 shares and now owns 8.80 million shares. Patterson Uti Energy Inc (NASDAQ:PTEN) was raised too.

Analysts await Marathon Oil Corporation (NYSE:MRO) to report earnings on May, 2 after the close. They expect $0.13 EPS, up 285.71% or $0.20 from last year’s $-0.07 per share. MRO’s profit will be $110.93M for 34.65 P/E if the $0.13 EPS becomes a reality. After $0.07 actual EPS reported by Marathon Oil Corporation for the previous quarter, Wall Street now forecasts 85.71% EPS growth.

Investors sentiment decreased to 0.88 in Q4 2017. Its down 0.04, from 0.92 in 2017Q3. It worsened, as 51 investors sold MRO shares while 191 reduced holdings. 68 funds opened positions while 145 raised stakes. 664.17 million shares or 0.25% less from 665.82 million shares in 2017Q3 were reported. Texan Mgmt holds 0.62% or 56,485 shares. Walleye Trading invested in 213,629 shares or 0.02% of the stock. Amundi Pioneer Asset has invested 0.1% in Marathon Oil Corporation (NYSE:MRO). First Manhattan stated it has 0% in Marathon Oil Corporation (NYSE:MRO). Lazard Asset Ltd Limited Liability Company has 0.02% invested in Marathon Oil Corporation (NYSE:MRO) for 505,342 shares. Guardian Life Insur Of America stated it has 2,754 shares or 0.01% of all its holdings. Parkside Fin Bankshares stated it has 314 shares. Norinchukin Retail Bank The reported 67,933 shares. Carroll Fincl Associate Inc has 0% invested in Marathon Oil Corporation (NYSE:MRO). Allen Invest Mgmt holds 0.02% or 29,055 shares. New York-based Highbridge Cap Mgmt Ltd Liability Co has invested 0.01% in Marathon Oil Corporation (NYSE:MRO). Thomas White Limited has 0.19% invested in Marathon Oil Corporation (NYSE:MRO). Alabama-based Leavell has invested 0.03% in Marathon Oil Corporation (NYSE:MRO). Old Mutual Customised Solutions (Proprietary) Ltd has 0.13% invested in Marathon Oil Corporation (NYSE:MRO). Boothbay Fund Mgmt Ltd invested in 20,300 shares or 0.05% of the stock.

Among 33 analysts covering Marathon Oil Corporation (NYSE:MRO), 17 have Buy rating, 0 Sell and 16 Hold. Therefore 52% are positive. Marathon Oil Corporation had 115 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Marathon Oil Corporation (NYSE:MRO) earned “Overweight” rating by Atlantic Securities on Friday, October 30. As per Friday, March 10, the company rating was upgraded by Susquehanna. The stock of Marathon Oil Corporation (NYSE:MRO) earned “Hold” rating by BMO Capital Markets on Tuesday, October 10. The firm earned “Neutral” rating on Friday, July 21 by Citigroup. On Friday, August 7 the stock rating was downgraded by TheStreet to “Hold”. The stock has “Buy” rating by Bank of America on Tuesday, August 16. The firm earned “Buy” rating on Tuesday, December 19 by Seaport Global. The stock of Marathon Oil Corporation (NYSE:MRO) earned “Underweight” rating by JP Morgan on Wednesday, December 9. Instinet downgraded the shares of MRO in report on Thursday, December 15 to “Neutral” rating. Bank of America upgraded Marathon Oil Corporation (NYSE:MRO) rating on Thursday, January 4. Bank of America has “Buy” rating and $21.0 target.

Marathon Oil Corporation (NYSE:MRO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.